NCT02339571 2026-04-13A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced MelanomaNational Cancer Institute (NCI)Phase 2/3 Active not recruiting600 enrolled
NCT04929041 2026-04-13Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 NegativeNational Cancer Institute (NCI)Phase 2/3 Suspended427 enrolled